Sea Moss for Interstitial Lung Disease: Anti-Fibrotic, Antioxidant & Pulmonary Support

Interstitial lung disease (ILD) encompasses a spectrum of progressive fibrotic lung diseases -- including idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis, and ILD secondary to connective tissue diseases. ILD is driven by TGF-beta1 fibrosis signaling, myofibroblast activation, oxidative alveolar damage, and chronic inflammation. Sea moss fucoidan demonstrates anti-fibrotic properties via TGF-beta inhibition; selenium supports GPx antioxidant protection of alveolar epithelium; omega-3 precursors modulate fibrotic eicosanoid pathways; zinc supports alveolar epithelial repair. Antifibrotic drugs (nintedanib, pirfenidone for IPF) and immunosuppressants (for inflammatory ILD) are standard; sea moss provides pulmonary nutritional support alongside pulmonologist care.

Read the full guide